Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
RESPONSE GENETICS INC (RGDX)
|
Add to portfolio |
|
|
|
| Price: |
$2.26
| | Metrics |
| OS: |
38.8
|
M
| |
|
|
| Market cap: |
$87.7
|
M
| |
-349
|
% ROIC
|
|
Net cash:
|
$87.9
|
k
| |
$0.00
|
per share
|
|
EV:
|
$87.6
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($12.4)
|
M
| |
|
|
|
EBIT
|
($13.2)
|
M
| |
|
|
| EPS |
($0.37)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 16.7 | 19.8 | 18.7 | 0.0 | 21.3 | 9.1 | 7.1 | 7.8 |
| Revenue growth | -15.6% | 5.7% | | -100.0% | 134.7% | 27.3% | -8.5% | |
| Cost of goods sold | 10.4 | 10.5 | 10.4 | 0.0 | 10.5 | 5.9 | 4.0 | 4.0 |
| Gross profit | 6.3 | 9.3 | 8.3 | 0.0 | 10.8 | 3.2 | 3.2 | 3.7 |
| Gross margin | 37.5% | 47.2% | 44.4% | | 50.8% | 35.3% | 44.3% | 48.1% |
| Selling, general and administrative | | | | 0.0 | | | | |
| Sales and marketing | 5.1 | 5.4 | 5.1 | 0.0 | 6.0 | 3.5 | 0.9 | |
| Research and development | 1.7 | 1.6 | 2.1 | | 1.6 | 2.3 | 2.1 | 2.5 |
| General and administrative | 12.9 | 10.3 | 8.8 | 0.0 | 8.1 | 6.0 | 6.7 | 5.2 |
| EBITA | -12.2 | -7.3 | -7.2 | 1.0 | -4.9 | -9.4 | -9.9 | -5.5 |
| EBITA margin | -72.8% | -36.9% | -38.4% | | -22.9% | -103.8% | -138.4% | -70.6% |
| Amortization of intangibles | 0.8 | 0.6 | 0.5 | 0.4 | | | | |
| EBIT | -13.0 | -7.9 | -7.7 | 0.7 | -4.9 | -9.4 | -9.9 | -5.5 |
| EBIT margin | -77.8% | -40.1% | -40.9% | | -22.9% | -103.8% | -138.4% | -70.6% |
| Pre-tax income | -13.7 | -8.0 | -7.8 | 0.7 | -4.7 | -9.3 | -9.5 | -5.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | | 0.1% | 0.1% | |
| Net income | -13.7 | -8.0 | -7.8 | 0.7 | -4.7 | -9.3 | -9.5 | -5.5 |
| Net margin | -81.9% | -40.5% | -41.4% | | -21.9% | -103.0% | -133.1% | -70.2% |
| |
| Diluted EPS | ($0.35) | ($0.24) | ($0.29) | $0.04 | ($0.26) | ($0.70) | ($0.93) | ($0.78) |
| Shares outstanding (diluted) | 38.8 | 33.5 | 26.7 | 17.0 | 17.8 | 13.3 | 10.2 | 7.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|